- VectivBio Holdings ( NASDAQ: VECT ) has filed for a $350M mixed shelf offering.
- The filing does not necessarily indicate that a sale has begun, or will occur in the future.
- The company intends to use the proceeds for pipeline development, general corporate purposes, and working capital.
- The offering can include ordinary shares, debt securities, warrants, and units.
- Read why Seeking Alpha contributor Alberto Abaterusso, who has a buy rating on shares, says that the biotech could be a takeover target .
For further details see:
VectivBio files for $350M mixed shelf offering